These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12538354)

  • 1. Affinity with Raf is sufficient for Ras to efficiently induce rat mammary carcinomas.
    McFarlin DR; Lindstrom MJ; Gould MN
    Carcinogenesis; 2003 Jan; 24(1):99-105. PubMed ID: 12538354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras effector mutant expression suggest a negative regulator inhibits lung tumor formation.
    Vandal G; Geiling B; Dankort D
    PLoS One; 2014; 9(1):e84745. PubMed ID: 24489653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of the amino acid residue at position 31 of the c-Ha-Ras protein with Raf-1 and RalGDS.
    Shirouzu M; Morinaka K; Koyama S; Hu CD; Hori-Tamura N; Okada T; Kariya K; Kataoka T; Kikuchi A; Yokoyama S
    J Biol Chem; 1998 Mar; 273(13):7737-42. PubMed ID: 9516482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor.
    Sreeramaneni R; Chaudhry A; McMahon M; Sherr CJ; Inoue K
    Mol Cell Biol; 2005 Jan; 25(1):220-32. PubMed ID: 15601844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harvey ras results in a higher frequency of mammary carcinomas than Kirsten ras after direct retroviral transfer into the rat mammary gland.
    Thompson TA; Kim K; Gould MN
    Cancer Res; 1998 Nov; 58(22):5097-104. PubMed ID: 9823318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
    Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
    Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model.
    Köhler M; Ehrenfeld S; Halbach S; Lauinger M; Burk U; Reischmann N; Cheng S; Spohr C; Uhl FM; Köhler N; Ringwald K; Braun S; Peters C; Zeiser R; Reinheckel T; Brummer T
    Oncogene; 2019 Feb; 38(8):1324-1339. PubMed ID: 30659267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H-Ras/mitogen-activated protein kinase pathway inhibits integrin-mediated adhesion and induces apoptosis in osteoblasts.
    Tanaka Y; Nakayamada S; Fujimoto H; Okada Y; Umehara H; Kataoka T; Minami Y
    J Biol Chem; 2002 Jun; 277(24):21446-52. PubMed ID: 11934900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of mitogen-activated protein kinases in the induction of parathyroid hormone-related peptide.
    Aklilu F; Gladu J; Goltzman D; Rabbani SA
    Cancer Res; 2000 Mar; 60(6):1753-60. PubMed ID: 10749150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways.
    Shields JM; Rogers-Graham K; Der CJ
    J Biol Chem; 2002 Mar; 277(12):9790-9. PubMed ID: 11773051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat mammary carcinogenesis induced by in situ expression of constitutive Raf kinase activity is prevented by tethering Raf to the plasma membrane.
    McFarlin DR; Gould MN
    Carcinogenesis; 2003 Jun; 24(6):1149-53. PubMed ID: 12807745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes.
    Gohlke H; Kiel C; Case DA
    J Mol Biol; 2003 Jul; 330(4):891-913. PubMed ID: 12850155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-3-3 antagonizes Ras-mediated Raf-1 recruitment to the plasma membrane to maintain signaling fidelity.
    Light Y; Paterson H; Marais R
    Mol Cell Biol; 2002 Jul; 22(14):4984-96. PubMed ID: 12077328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
    Fan S; Meng Q; Laterra JJ; Rosen EM
    Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells.
    Oldham SM; Clark GJ; Gangarosa LM; Coffey RJ; Der CJ
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6924-8. PubMed ID: 8692920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COMBINE analysis of the specificity of binding of Ras proteins to their effectors.
    Tomić S; Bertosa B; Wang T; Wade RC
    Proteins; 2007 May; 67(2):435-47. PubMed ID: 17295314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of gene induction and cell growth by the Ras effector Rlf.
    Wolthuis RM; de Ruiter ND; Cool RH; Bos JL
    EMBO J; 1997 Nov; 16(22):6748-61. PubMed ID: 9362489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
    Ulkü AS; Schäfer R; Der CJ
    Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells.
    Kato-Stankiewicz J; Hakimi I; Zhi G; Zhang J; Serebriiskii I; Guo L; Edamatsu H; Koide H; Menon S; Eckl R; Sakamuri S; Lu Y; Chen QZ; Agarwal S; Baumbach WR; Golemis EA; Tamanoi F; Khazak V
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14398-403. PubMed ID: 12391290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.